Immune Cells vs. Cancer: What Are CAR T-Cells and How Do They Work?
One of the newest things in cancer therapy is the idea that we can harness the immune system to attack cancer. So how do we make that work?
Charles Sentman, PhD, professor of microbiology and immunology, explains how specially engineered immune cells—called CAR T-cells—locate and destroy tumor cells. Sentman and his collaborators at the Geisel School of Medicine and Dartmouth’s Thayer School of Engineering have designed a new line of CAR T-cells that can potentially target 80–90% of all types of tumor cells. His first line of CAR-T cells is currently in clinical trials for seven different kinds of cancer.
Learn more about cancer immunotherapy and innovation: http://dartgo.org/campaign-immunotherapy
Video Production: Jennifer Durgin and Sarah Sentman, Office of Development and Alumni Relations, Geisel School of Medicine at Dartmouth.
Animation: Laura Porat, Los Angeles, California. https://lauraporat.com